Eric Dein, MD, RhMSUS
Institute of Rheumatic and Autoimmune Diseases, Overlook Hospital
Jersey City, New Jersey, United States
Disclosure information not submitted.
Jennifer Grossman, MD
UCLA
Sherman Oaks, CA, United States
Disclosure(s): american board of internal medicine: Advisor or Review Panel Member (Ongoing); AstraZeneca: Grant/Research Support (Ongoing); exact sciences: Stock options or bond holdings in a for-profit corporation or self-directed pension plan (Ongoing); GlaxoSmithKlein(GSK): Grant/Research Support (Ongoing); ilumina: Stock options or bond holdings in a for-profit corporation or self-directed pension plan (Ongoing); iqvia: Stock options or bond holdings in a for-profit corporation or self-directed pension plan (Ongoing); Lupus Foundation of America: Officer or Board Member (Ongoing); Merck/MSD: Stock options or bond holdings in a for-profit corporation or self-directed pension plan (Ongoing); rheumatology research foundation: Grant/Research Support (Ongoing)
From fevers to swollen joints to cytopenias, non-rheumatology diseases can have presentations that mimic autoimmune disease. Expert clinicians are required to maintain a broad diagnosis, including infectious, hematologic/oncologic, and rheumatic etiologies. Participants will be invited to engage in interactive case-based learning on the evaluation, work-up, and treatment of rheumatology mimics
Speaker: Leonard Calabrese, DO – Cleveland Clinic
Speaker: Cassandra Calabrese, DO – Cleveland Clinic Foundation